United States · Series A startup

Who invested in Evive

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechFoodtechHealthcare

Funding summaryUpdated 26 Oct 2026

$47Mraised across 2 rounds since 2018, from 2 sources

$43MRound$3.9MSeries A
Latest round
Series A, $3.9MJun 2020
Biggest round
$43MRound · Jan 2018
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201820192020
$43MRound$3.9MSeries A
First round
Round, $43M
Jan 2018
Biggest round
$43M
Round · Jan 2018
Between rounds
2.4 years
from the last two

The rounds

  1. Jun 2020
    Series A$3.9M1 new

    Source recorded

  2. Jan 2018
    Round$43M1 new

    Reported by FinSMEsSEC filing: $43M sold, first sale Nov 2017

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

BDC CapitalVC firm1round
Susquehanna Growth EquityPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Evive

Who invested in Evive?

Evive's investors include BDC Capital and Susquehanna Growth Equity.

How much has Evive raised?

Evive has raised $47M across 2 rounds since 2018.

When did Evive last raise?

Evive's most recent round was a Series A of $3.9M in Jun 2020.

What was Evive's biggest round?

Evive's largest round on record is $43M (Undisclosed round), in Jan 2018.

Who backed Evive first?

Evive's first round on record, in Jan 2018, was backed by Susquehanna Growth Equity.

What stage is Evive at?

Evive's latest named round is a Series A, in Jun 2020.

Where is Evive based?

Evive is based in the United States.

Companies like Evive

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.